American Renal Associates Holdings Inc logo

ARA - American Renal Associates Holdings Inc Share Price

$11.47 0.0  0.0%

Last Trade - 15/01/21

Sector
Healthcare
Size
Small Cap
Market Cap £291.6m
Enterprise Value £816.0m
Revenue £599.2m
Position in Universe 3500th / 6547
Bullish
Bearish
Unlock ARA Revenue
Momentum
Relative Strength (%)
1m -1.84%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -4.26%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
560.7 653 766.8 729 805.8 822.5 817.6 835.3 +8.0%
+911.3 +16.3 -75.9
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2020,American Renal Associates Holdings Inc revenues decreased1% to $608M. Net loss applicable to common stockholdersdecreased 33% to $9.8M. Revenues reflect a decrease indemand for the Company's products and services due tounfavorable market conditions. Lower net loss reflectsCertain legal and other matters decrease of 59% to $9.5M(expense), Interest Expense.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for ARA
Graphical History

Revenue

ARA Revenue Unlock ARA Revenue

Net Income

ARA Net Income Unlock ARA Revenue

Normalised EPS

ARA Normalised EPS Unlock ARA Revenue

PE Ratio Range

ARA PE Ratio Range Unlock ARA Revenue

Dividend Yield Range

ARA Dividend Yield Range Unlock ARA Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ARA EPS Forecasts Unlock ARA Revenue
Profile Summary

American Renal Associates Holdings, Inc. is a dialysis service provider in the United States focused on joint venture (JV) partnerships with physicians. As of December 31, 2016, the Company owned and operated 214 dialysis clinics in partnership with 379 nephrologist partners treating over 14,000 patients in 25 states and the District of Columbia. The Company operates its dialysis clinics exclusively through a JV model, in which it partners primarily with local nephrologists to develop, own and operate dialysis clinics, while the providers of the majority of dialysis services in the United States operate through a combination of subsidiaries and joint ventures. It provides patient care and clinical outcomes to patients suffering from end-stage renal disease (ESRD). Its clinics offer both in center and home dialysis options to meet the needs of patients. Its clinics primarily provide in center hemodialysis treatments and ancillary items and services.

Directors
Last Annual December 31st, 2019
Last Interim September 30th, 2020
Incorporated March 18, 2010
Public Since April 21, 2016
No. of Shareholders: 217
No. of Employees: 4,977
Sector Healthcare
Industry Healthcare Providers & Services
Index
Exchange New York Stock Exchange
Shares in Issue 34,543,295
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ARA Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ARA
Upcoming Events for ARA
Monday 15th March, 2021 Estimate
Q4 2020 American Renal Associates Holdings Inc Earnings Release
Thursday 29th April, 2021 Estimate
American Renal Associates Holdings Inc Annual Shareholders Meeting
Monday 10th May, 2021 Estimate
Q1 2021 American Renal Associates Holdings Inc Earnings Release
Frequently Asked Questions for American Renal Associates Holdings Inc
What is the American Renal Associates Holdings Inc share price?

As of 15/01/21, shares in American Renal Associates Holdings Inc are trading at $11.47, giving the company a market capitalisation of £291.6m. This share price information is delayed by 15 minutes.

How has the American Renal Associates Holdings Inc share price performed this year?

Shares in American Renal Associates Holdings Inc are currently trading at $11.47 and the price has moved by 16.57% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the American Renal Associates Holdings Inc price has moved by 2.26% over the past year.

What are the analyst and broker recommendations for American Renal Associates Holdings Inc?

Of the analysts with advisory recommendations for American Renal Associates Holdings Inc, there are there are currently 0 "buy" , 3 "hold" and 0 "sell" recommendations. The overall consensus recommendation for American Renal Associates Holdings Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will American Renal Associates Holdings Inc next release its financial results?

American Renal Associates Holdings Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the American Renal Associates Holdings Inc dividend yield?

American Renal Associates Holdings Inc does not currently pay a dividend.

Does American Renal Associates Holdings Inc pay a dividend?

American Renal Associates Holdings Inc does not currently pay a dividend.

When does American Renal Associates Holdings Inc next pay dividends?

American Renal Associates Holdings Inc does not currently pay a dividend.

How do I buy American Renal Associates Holdings Inc shares?

To buy shares in American Renal Associates Holdings Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of American Renal Associates Holdings Inc?

Shares in American Renal Associates Holdings Inc are currently trading at $11.47, giving the company a market capitalisation of £291.6m.

Where are American Renal Associates Holdings Inc shares listed? Where are American Renal Associates Holdings Inc shares listed?

Here are the trading details for American Renal Associates Holdings Inc:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: ARA
What kind of share is American Renal Associates Holdings Inc?

Based on an overall assessment of its quality, value and momentum, American Renal Associates Holdings Inc is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a American Renal Associates Holdings Inc share price forecast 2021?

Shares in American Renal Associates Holdings Inc are currently priced at $11.47. At that level they are trading at 12.82% premium to the analyst consensus target price of 0.00.

Analysts covering American Renal Associates Holdings Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.16 for the next financial year.

How can I tell whether the American Renal Associates Holdings Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like American Renal Associates Holdings Inc. Over the past six months, the relative strength of its shares against the market has been 43.67%. At the current price of $11.47, shares in American Renal Associates Holdings Inc are trading at 37.83% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the American Renal Associates Holdings Inc PE Ratio?

We were not able to find PE ratio data for American Renal Associates Holdings Inc.

Who are the key directors of American Renal Associates Holdings Inc?

American Renal Associates Holdings Inc's management team is headed by:

Joseph Carlucci - CHM
Syed Kamal - PRE
Michael Boxer - IND
Thomas Erickson - IND
Robert Fish - IND
Susanne Clark - IND
Don Williamson - COO
Mark Herbers - CFO
Jeremy Gelber - IND
Who are the major shareholders of American Renal Associates Holdings Inc?

Here are the top five shareholders of American Renal Associates Holdings Inc based on the size of their shareholding:

Centerbridge Partners, L.P. Private Equity
Percentage owned: 51% (17.6m shares)
Van Berkom & Associates Inc. Investment Advisor
Percentage owned: 8.37% (2.89m shares)
Kamal (Syed T) Individual Investor
Percentage owned: 3.74% (1.29m shares)
Carlucci (Joseph A) Individual Investor
Percentage owned: 3.6% (1.25m shares)
Renaissance Technologies LLC Hedge Fund
Percentage owned: 3.24% (1.12m shares)
Similar to ARA
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.